Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tokio Onodera is active.

Publication


Featured researches published by Tokio Onodera.


Cancer | 1992

Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on yoshida sarcoma-bearing rats

Narihide Goseki; Sigeru Yamazaki; Tokio Onodera; Goro Kosaki; Yutaka Hibino; Tokuo Kuwahata

Methionine‐depleting total parenteral nutrition (methionine‐depleting TPN), which infuses an amino acid solution devoid of L‐methionine and L‐cysteine as the sole protein source, showed enhancement of the effect of several anti‐cancer agents. In this study, the combined effect of the methionine‐depleting TPN with the administration of doxorubicin was examined in Yoshida sarcoma (YS)‐bearing rats with regard to effects on the primary tumor growth, the extension of metastasis, and the host animals life span.


Annals of Surgery | 1991

Anti-tumor effect of L-methionine-deprived total parenteral nutrition with 5-fluorouracil administration on Yoshida sarcoma-bearing rats.

Narihide Goseki; Tokio Onodera; Goro Kosaki

L-methionine-deprived total parenteral nutrition (methionine-deprived TPN), infusing amino acid solution devoid of L-methionine and L-cysteine by the method of TPN as an only protein source, showed enhancement of the effect of several anti-cancer agents. In this study the combined effect of the methionine-deprived TPN with administration of 5-fluorouracil (5-FU) was examined in Yoshida Sarcoma (YS)-bearing rats, from aspects of effects on the tumor metastasis and the host animals life span, in the following four groups treated with: methionine-deprived TPN with administration of 5-FU, methionine-deprived TPN without administration of 5-FU, L-methionine-contained TPN plus 5-FU, and L-methionine-contained TPN without 5-FU. In the first experiment, TPN was continued for 8 days in the four groups, and the anti-cancer effect of methionine-deprived TPN and administration of 5-FU based on both the growth of the primary tumor at the implanted site and the tumor metastasis was studied from the view point of pathologic findings of animals killed immediately after these treatments. In experiment 2 the survival period was examined after these treatments for 10 days with subsequent oral feeding until death. The results were as follows: proliferation of YS, transplanted subcutaneously, was markedly suppressed; particularly hematogenous metastasis, characteristic in YS, was prominently blunted then obtained an apparent longer survival period in rats treated with the methionine-deprived TPN with administration of 5-FU.


International Journal of Gastrointestinal Cancer | 1994

Intraoperative radiation therapy for pancreatic carcinoma

Atsutake Okamoto; Kohji Tsuruta; Tomoaki Isawa; Terumi Kamisawa; Yoshiaki Tanaka; Tokio Onodera

SummaryNinety patients with carcinoma of the pancreas treated between 1976 and 1990 were reviewed retrospectively. Intraoperative radiation therapy (IORT) in combination with external beam radiation therapy (EBRT) for localized but unresectable tumors (n = 29) prolonged survival significantly more than IORT alone (n = 16) (p < 0.01); it seems EBRT enhanced or contributed to the better results obtained with IORT plus EBRT. Moreover, IORT, alone or in combination, relieved pain. Adjuvant IORT for residual tumors (n = 20) might not effectively prolong survival, because the difference in survival rate between noncurative resection plus IORT and nonresection plus IORT in combination with EBRT was not significant. Curative tumor resection of stage III disease in combination with IORT (n = 9) resulted in significantly longer survival as compared with curative tumor resection alone (n = 8) (p < 0.05). It may be advisable to administer IORT in combination with EBRT to patients with advanced pancreatic carcinoma, avoiding aggressive tumor resection, when curative tumor resection cannot be performed.


Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1992

Intraoperative Radiation Therapy in Combination with Conformation Radiation Therapy for Localized Unresectable Pancreatic Carcinoma. An Analysis of 13 Patients Survived for More than One Year.

Atsutake Okamoto; Kohji Tsuruta; Yoshiaki Tanaka; Tokio Onodera

遠隔転移のない切除不能の進行膵癌46例に対し術中照射療法を行い, 30例に主に原体照射法による術後外部照射を追加した.外部照射併用30例中13例が1年以上生存 (最長生存20か月, 2例), 1年生存率は46.4% (median survival 11か月) であった.これに対し術中照射単独16例には1年生存はなくmedian survivalは6.2か月であった.両群間で生存率に有意差を認めた (p<0.01).1年以上生存した7例の剖検所見の特徴は, 肉眼的には腫瘍の著明な縮小であり, 組織学的には腫瘍の硝子化と線維化およびその内部に存在する変性や壊死に陥った癌細胞であったが, 腫瘍は周辺から後腹膜組織, 周囲臓器へとscirrhousに浸潤する傾向にあった.また術中照射は治療前に癖痛を訴えていた28例の内16例 (57%) に落痛の消失をもたらし, 1年以上の延命とquality of lifeの向上に寄与した.


Tohoku Journal of Experimental Medicine | 1987

Inhibitory effect of L-methionine-deprived amino acid imbalance using total parenteral nutrition on growth of ascites hepatoma in rats.

Narihide Goseki; Tokio Onodera; Morio Koike; Goro Kosaki


Tohoku Journal of Experimental Medicine | 1989

Influence of L-methionine-deprived total parenteral nutrition on the tumor tissue and plasma amino acids fraction and the host metabolism: Experimental study with Sato lung carcinoma-bearing rats.

Narihide Goseki; Tokio Onodera; Goro Kosaki


Tohoku Journal of Experimental Medicine | 1988

Effect of Intraoperative Radiotherapy on Pancreatic Carcinoma: Histopathological Findings from Autopsy Cases

Narihide Goseki; Morio Koike; Atsutake Okamoto; Tokio Onodera; Tadayoshi Matsuda


Tohoku Journal of Experimental Medicine | 1968

Experimental peritonitis produced by gastric juice,bile or feces

Tokio Onodera; Masahiro Onuma; Gentaro Miura; Morio Kasai


Tohoku Journal of Experimental Medicine | 1968

Effect of Fluid and Antibiotic Administration on Experimental Fecal Peritonitis

Tokio Onodera; Masahiro Onuma; Yoshiyuki Okada; Shigeru Matsuoka; Morio Kasai


Kanzo | 1991

Hepatocellular carcinoma with a tumor thrombus in the portal confluence. A case report on a 10-year survivor.

Atsutake Okamoto; Kohji Tsuruta; Satoshi Tanaka; Morio Koike; Akira Machii; Tokio Onodera

Collaboration


Dive into the Tokio Onodera's collaboration.

Top Co-Authors

Avatar

Narihide Goseki

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Morio Koike

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sigeru Yamazaki

Tokyo Medical and Dental University

View shared research outputs
Researchain Logo
Decentralizing Knowledge